Advances in Cancer Biology - Metastasis · 2022 · 63 citations · 63 references
PharmacyOncologyPharmaceuticsDrug DeliveryNanoparticle Drug DeliveryTargeted Drug DeliveryCancer Drug DeliveryCancer NanomedicineNanomaterials For Drug DeliveryNanomedicineNanoparticle Delivery SystemsNanoparticle FormulationsCancer NanotherapyDrug Delivery NanocarriersMonoclonal Antibodies In CancerMultifunctional NanoparticlesNanocarriersNanoparticle-based ChemotherapyTargeted DeliveryTherapeutic Efficacy Assessment
Breast cancer is a challenging health issue in women and the second-leading cause of mortality around world. In this review, we addressed beneficial role of siRNA to control breast cancer. Various limitations of siRNA based therapeutic approaches, innate challenges siRNA delivery, in vitro and in vivo findings have been highlighted to focus recent advancement to control breast cancer. The current approaches and comparative assessment against conventional chemotherapeutics methods have been thoroughly investigated for the conclusive outcomes. Various nanocomposites and nanomedicines with or without surface functionalization have played a major role for convincing impact of siRNA delivery for anticipated therapeutic efficacy by stabilization and protecting bio-active siRNA in in-vitro and in-vivo condition. Various targeted genes for siRNA knockdown were reported to control breast cancer by tuning its biological performance in nanocarrier systems. Conclusively, siRNA loaded nanocarriers are promising option to control breast cancer compared to conventional (druggable) and mAbs (monoclonal antibodies) based therapy.
63
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Metastatic Behavior of Breast Cancer Subtypes
Hagen F. Kennecke, Rinat Yerushalmi, Ryan Woods et al. · Journal of Clinical Oncology · 2010 · 2.3K citations · Full text
Medicine, Cancer Biology, Oncology +14
Rational siRNA design for RNA interference
Angela Reynolds, Devin Leake, Queta Boese et al. · Nature Biotechnology · 2004 · 2.1K citations
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Sohrab P. Shah, Andrew Roth, Rodrigo Goya et al. · Nature · 2012 · 2K citations
Heterogeneity in breast cancer
Kornélia Polyák · Journal of Clinical Investigation · 2011 · 1K citations · Full text
Medicine, Cancer Biology, Oncology +17